Caitlin John, LLC Emergent Bio Solutions Inc. Transaction History
Caitlin John, LLC
- $151 Billion
- Q4 2024
A detailed history of Caitlin John, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Caitlin John, LLC holds 1,350 shares of EBS stock, worth $12,784. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,350
Previous 1,000
35.0%
Holding current value
$12,784
Previous $9.97 Million
29.45%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
159Shares Held
34.4MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$30.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$20.2 Million0.01% of portfolio
-
State Street Corp Boston, MA1.91MShares$18.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$14.6 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $472M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...